![Alexander Casdin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Casdin
Direttore/Membro del Consiglio presso
ERASCA, INC.
Patrimonio netto: 12 M $ in data 30/06/2026
Profilo
Alexander Whitman Casdin is the founder of Casdin Advisors LLC.
Mr. Casdin is Chief Executive Officer at Epirium Bio, Inc. since 2025.
Mr. Casdin is Treasurer & Director at Conquer Cancer Foundation of the American Society of Clinical since 2015.
Mr. Casdin is Independent Director at Erasca, Inc. since 2018.
Mr. Casdin is Member-Presidents Leadership Council at Brown University.
Mr. Casdin was Chief Executive Officer at Reneo Capital Management LP from 2013 to 2020.
Mr. Casdin was Independent Director at DUSA Pharmaceuticals, Inc. from 2009 to 2012.
Mr. Casdin was Director at DiaVacs, Inc. Mr. Casdin was Independent Director at Ignyta, Inc. from 2013 to 2018.
Mr. Casdin was Independent Director at Project Sage Oldco, Inc. from 2023 to 2024.
Mr. Casdin was Vice President-Finance at Amylin Pharmaceuticals, Inc. from 2009 to 2011.
Mr. Casdin was Portfolio Manager at Pequot Capital Management, Inc. in 2001.
Mr. Casdin was Managing Partner at Cooper Hill Partners LLC (Investment Management) from 2001 to 2005.
Mr. Casdin was Chief Financial Officer at Sophiris Bio, Inc. from 2011 to 2012.
Mr. Casdin was Member-Artists Council at Whitney Museum of American Art.
Mr. Casdin was Advisor at Mountain Group Partners LLC.
Mr. Casdin completed undergraduate studies at Brown University.
Mr. Casdin earned an MBA degree from Columbia Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ERASCA, INC. 0,21% | 26/06/2026 | 667.724 ( 0,21% ) | 12 M $ | 30/06/2026 |
Posizioni attive di Alexander Casdin
| Società | Posizione | Inizio |
|---|---|---|
| ERASCA, INC. | Direttore/Membro del Consiglio | 02/07/2018 |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Amministratore Delegato | 01/01/2025 |
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Direttore/Membro del Consiglio | 01/12/2015 |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Alexander Casdin
| Società | Posizione | Fine |
|---|---|---|
| PROJECT SAGE OLDCO, INC. | Direttore/Membro del Consiglio | 28/06/2024 |
Reneo Capital Management LP
 Reneo Capital Management LP Investment ManagersFinance Provides investment advice | Amministratore Delegato | 01/10/2020 |
| IGNYTA INC | Direttore/Membro del Consiglio | 07/02/2018 |
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Direttore/Membro del Consiglio | 01/12/2012 |
| SOPHIRIS BIO | Direttore Finanziario/CFO | 14/09/2012 |
Formazione di Alexander Casdin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
DUSA Pharmaceuticals, Inc.
DUSA Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets photodynamic therapies & dermatological pharmaceutical products | Health Technology |
Pequot Capital Management, Inc.
 Pequot Capital Management, Inc. Investment ManagersFinance Pequot Capital Management's investment philosophy is based on deep fundamental research and unbiased thematic analysis to identify and capitalize on market inefficiencies across an industry sector or a company's lifecycle. The firm invests in public equities, private equity, venture capital, distressed securities and a variety of fixed-income securities. Pequot Capital Management tends to invest in the stocks of US small-cap companies in the consumer services, health technology and commercial services sectors. They maintain a very high turnover rate. | Finance |
Cooper Hill Partners LLC (Investment Management)
 Cooper Hill Partners LLC (Investment Management) Investment ManagersFinance Copper is a longer-term, high portfolio turnover shop with a focus on value. They invest long/short in the biotechnology sector. | Finance |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Epirium Bio, Inc.
Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems | Health Technology |
DiaVacs, Inc.
 DiaVacs, Inc. BiotechnologyHealth Technology Develops and commercializes cell-based therapys for treatment of type 1 diabetes | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitney Museum of American Art
 Whitney Museum of American Art Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Mountain Group Partners LLC
 Mountain Group Partners LLC Investment ManagersFinance Mountain Group Partners invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, healthcare and disruptive technology. It provides financing for early-stage capital requirements. | Finance |
Project Sage Oldco, Inc.
 Project Sage Oldco, Inc. Medical SpecialtiesHealth Technology Develops and sells medical aesthetics products | Health Technology |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Improves cancer care and prevention | Commercial Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reneo Capital Management LP
Reneo Capital Management LP Investment ManagersFinance Provides investment advice | Finance |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Casdin Advisors LLC |
